IMVT - Financial Reports List - Immunovant, Inc. - IntrinsicAlpha

Immunovant, Inc. IMVT

Healthcare - Biotechnology - NASDAQ - US

$ 14.39

-1.3 %

$ 2.44 B

Market Cap

-5.49

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q3	8-K	2024-12-31	0.00%	-116.11%	-121.83%
Quarterly Report	Q2	8-K	2024-09-30	0.00%	-86.01%	-98.84%
Quarterly Report	Q1	8-K	2024-06-30	0.00%	-17.87%	-27.50%
Quarterly Report	Q4	8-K	2024-03-31	0.00%	-26.73%	-25.76%
Annual Report	FY	10-K	2024-03-31	0.00%	-22.93%	-42.44%
Quarterly Report	Q3	8-K	2023-12-31	0.00%	18.68%	-17.03%
Quarterly Report	Q2	8-K	2023-09-30	0.00%	-22.40%	-17.32%
Quarterly Report	Q1	8-K	2023-06-30	0.00%	-83.13%	-83.15%
Quarterly Report	Q4	8-K	2023-03-31	0.00%	-25.99%	-36.07%
Annual Report	FY	10-K	2023-03-31	0.00%	-34.60%	-27.09%

1